BioCatalyst

BMS-986446 — catalyst calendar

1 verified catalyst event(s) referencing BMS-986446, each linked to its official source. Verified as of 2026-11-03.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-17
in 1mo
ESTIMATED
 READOUT
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Mon
Phase 2 · Alzheimer Disease, Early Onset
 BMY BRISTOL MYERS SQUIBB CO BMS-986446 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-03
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.